Stock News

Rigel Pharmaceuticals (RIGL) Shareholder Sio Capital Management Has Decreased Its Position by $2.03 Million; Homrich & Berg Trimmed Its Holding in American Tower New (AMT) as Valuation Rose

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Logo

Sio Capital Management Llc decreased its stake in Rigel Pharmaceuticals Inc (RIGL) by 43.39% based on its latest 2017Q4 regulatory filing with the SEC. Sio Capital Management Llc sold 678,252 shares as the company’s stock rose 8.02% while stock markets declined. The institutional investor held 885,055 shares of the health care company at the end of 2017Q4, valued at $3.43 million, down from 1.56 million at the end of the previous reported quarter. Sio Capital Management Llc who had been investing in Rigel Pharmaceuticals Inc for a number of months, seems to be less bullish one the $565.90M market cap company. The stock decreased 5.42% or $0.22 during the last trading session, reaching $3.84. About 15.40 million shares traded or 464.98% up from the average. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has risen 9.91% since April 23, 2017 and is uptrending. It has underperformed by 1.64% the S&P500.

Homrich & Berg decreased its stake in American Tower Corp New (AMT) by 54.69% based on its latest 2017Q4 regulatory filing with the SEC. Homrich & Berg sold 3,877 shares as the company’s stock rose 2.70% while stock markets declined. The institutional investor held 3,212 shares of the real estate investment trusts company at the end of 2017Q4, valued at $458,000, down from 7,089 at the end of the previous reported quarter. Homrich & Berg who had been investing in American Tower Corp New for a number of months, seems to be less bullish one the $59.11B market cap company. The stock decreased 0.58% or $0.8 during the last trading session, reaching $136.62. About 2.66M shares traded. American Tower Corporation (NYSE:AMT) has risen 20.37% since April 23, 2017 and is uptrending. It has outperformed by 8.82% the S&P500.

Sio Capital Management Llc, which manages about $116.75M and $177.32M US Long portfolio, upped its stake in Kura Oncology Inc by 116,296 shares to 392,027 shares, valued at $6.00 million in 2017Q4, according to the filing. It also increased its holding in Xencor Inc (NASDAQ:XNCR) by 76,881 shares in the quarter, for a total of 109,981 shares, and has risen its stake in Aetna Inc (NYSE:AET).

Investors sentiment increased to 2.06 in 2017 Q4. Its up 0.67, from 1.39 in 2017Q3. It increased, as 14 investors sold RIGL shares while 18 reduced holdings. 22 funds opened positions while 44 raised stakes. 127.13 million shares or 21.87% more from 104.32 million shares in 2017Q3 were reported. 1.93M are held by Rhenman And Prns Asset Mngmt. Moreover, Schwab Charles Invest has 0% invested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). 22,440 are owned by Parametric Port Limited Liability Corporation. Citadel Advsr Limited Liability Co holds 4.07M shares. Prelude Cap Llc holds 0% or 5,619 shares. Burney stated it has 0.01% of its portfolio in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). Maryland-based Proshare Lc has invested 0% in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). J Goldman And Communication LP holds 0.21% or 987,000 shares in its portfolio. Moreover, Teacher Retirement Sys Of Texas has 0% invested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) for 46,680 shares. Pura Vida Lc holds 1.74% of its portfolio in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) for 604,563 shares. Parallax Volatility Advisers Lp reported 0% in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). Comml Bank Of Mellon has 0% invested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). Goldman Sachs Gp Inc Inc accumulated 0% or 469,037 shares. Citigroup Inc has 178,098 shares. American Intll Gru holds 0% or 99,640 shares.

Among 6 analysts covering Rigel Pharmaceuticals (NASDAQ:RIGL), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Rigel Pharmaceuticals had 26 analyst reports since August 8, 2015 according to SRatingsIntel. As per Wednesday, April 18, the company rating was maintained by BMO Capital Markets. The stock of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has “Buy” rating given on Tuesday, April 3 by H.C. Wainwright. The firm has “Buy” rating by H.C. Wainwright given on Wednesday, August 31. Jefferies maintained Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) on Monday, September 4 with “Buy” rating. On Monday, November 6 the stock rating was reinitiated by H.C. Wainwright with “Buy”. BMO Capital Markets maintained the stock with “Buy” rating in Monday, October 2 report. The firm has “Buy” rating by BMO Capital Markets given on Tuesday, November 7. The firm earned “Buy” rating on Wednesday, April 18 by H.C. Wainwright. The rating was upgraded by Zacks to “Hold” on Saturday, August 8. The stock has “Buy” rating by H.C. Wainwright on Wednesday, March 7.

Analysts await Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to report earnings on May, 1. They expect $-0.17 earnings per share, down 30.77% or $0.04 from last year’s $-0.13 per share. After $-0.18 actual earnings per share reported by Rigel Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -5.56% EPS growth.

Investors sentiment increased to 1.25 in Q4 2017. Its up 0.05, from 1.2 in 2017Q3. It improved, as 47 investors sold AMT shares while 280 reduced holdings. 107 funds opened positions while 301 raised stakes. 377.89 million shares or 0.11% less from 378.31 million shares in 2017Q3 were reported. First Interstate Financial Bank holds 1,654 shares. Advisory Svcs Network Ltd Company holds 8,626 shares or 0.11% of its portfolio. 11,779 were accumulated by Private Advisor Gp Limited Liability. Eagle Asset has invested 0% in American Tower Corporation (NYSE:REIT). Bluefin Trading Ltd Limited Liability Company owns 0.08% invested in American Tower Corporation (NYSE:REIT) for 8,900 shares. Gamble Jones Counsel has 25,473 shares. Reaves W H accumulated 1.45% or 320,695 shares. Janney Capital Mgmt Limited Liability Com owns 85,086 shares. Ascend Capital Ltd Liability Corp owns 57,594 shares or 0.31% of their US portfolio. Salem Invest Counselors holds 0% of its portfolio in American Tower Corporation (NYSE:REIT) for 200 shares. Stratos Wealth Ltd owns 6,549 shares. The Connecticut-based Verition Fund Mngmt Lc has invested 0.05% in American Tower Corporation (NYSE:REIT). Arizona State Retirement System reported 128,490 shares. Perkins Coie Trust has 0.93% invested in American Tower Corporation (NYSE:REIT) for 13,032 shares. Northeast Invest holds 164,795 shares.

Since December 11, 2017, it had 0 insider purchases, and 7 sales for $15.20 million activity. 3,500 shares valued at $512,246 were sold by THOMPSON SAMME L on Tuesday, March 20. REED JOANN A sold 845 shares worth $124,071. SHARBUTT DAVID E sold $228,793 worth of American Tower Corporation (NYSE:REIT) on Wednesday, December 13. TAICLET JAMES D JR sold $4.94M worth of stock or 34,667 shares. Sharma Amit had sold 32,943 shares worth $4.57 million.

Homrich & Berg, which manages about $3.37 billion and $1.46 billion US Long portfolio, upped its stake in Ishares Tr (DGRO) by 21,018 shares to 104,485 shares, valued at $3.63 million in 2017Q4, according to the filing. It also increased its holding in Spdr S&P Midcap 400 Etf Tr (MDY) by 1,615 shares in the quarter, for a total of 2,374 shares, and has risen its stake in Kimberly Clark Corp (NYSE:KMB).

Among 19 analysts covering American Tower Corporation (NYSE:AMT), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. American Tower Corporation had 72 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, August 17 by Argus Research. The firm has “Buy” rating given on Monday, March 5 by Citigroup. Oppenheimer maintained it with “Buy” rating and $160.0 target in Wednesday, December 20 report. The stock of American Tower Corporation (NYSE:REIT) earned “Outperform” rating by Raymond James on Monday, June 12. The company was maintained on Tuesday, March 27 by Citigroup. The stock of American Tower Corporation (NYSE:REIT) earned “Buy” rating by Citigroup on Wednesday, August 10. The firm has “Buy” rating given on Monday, October 16 by Jefferies. On Tuesday, July 18 the stock rating was maintained by Cowen & Co with “Buy”. SunTrust initiated American Tower Corporation (NYSE:REIT) on Tuesday, September 13 with “Buy” rating. Morgan Stanley upgraded the stock to “Overweight” rating in Thursday, August 6 report.

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *